363 related articles for article (PubMed ID: 26733340)
1. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Kitajima K; Miyoshi Y
Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
[TBL] [Abstract][Full Text] [Related]
2. Impact of 18F-FDG PET/CT in the management decisions of breast cancer board on early-stage breast cancer.
Özdemir A; Güven M; Binici S; Uygur S; Toktaş O
Clin Transl Oncol; 2024 May; 26(5):1139-1146. PubMed ID: 37848693
[TBL] [Abstract][Full Text] [Related]
3. Current Role and Future Prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in the Management of Breast Cancer.
Robson N; Thekkinkattil DK
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399608
[TBL] [Abstract][Full Text] [Related]
4. Positron Emission Tomography/Computed Tomography Transformation of Oncology: Multiple Myeloma.
Murtazaliev S; Rowe SP; Sheikhbahaei S; Werner RA; Sólnes LB
PET Clin; 2024 Apr; 19(2):249-260. PubMed ID: 38199914
[TBL] [Abstract][Full Text] [Related]
5. PET/Computed Tomography Transformation of Oncology: Immunotherapy Assessment.
Ghodsi A; Hicks RJ; Iravani A
PET Clin; 2024 Apr; 19(2):291-306. PubMed ID: 38199917
[TBL] [Abstract][Full Text] [Related]
6. The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis.
Paez D; Giammarile F; Brink A; García-Pérez O; Estrada-Lobato E
Semin Nucl Med; 2024 May; 54(3):409-414. PubMed ID: 38688771
[TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging review of metastatic melanoma involving the breast.
Brodhead M; Woods RW; Fowler AM; Roy M; Neuman H; Gegios A
Curr Probl Diagn Radiol; 2024; 53(2):289-296. PubMed ID: 38307731
[TBL] [Abstract][Full Text] [Related]
8. Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies.
Ruby L; Jayaprakasam VS; Fernandes MC; Paroder V
Hematol Oncol Clin North Am; 2024 Jun; 38(3):711-730. PubMed ID: 38575457
[TBL] [Abstract][Full Text] [Related]
9. Quality and consistency of clinical practice guideline recommendations for PET/CT and PET: a systematic appraisal.
Li Q; Hou W; Wu M; Li L; Su M; Ma B; Cui F; Ren Y; Xu J; Zou K; Tian R; Sun X
Eur Radiol; 2023 Nov; 33(11):7879-7889. PubMed ID: 37314473
[TBL] [Abstract][Full Text] [Related]
10. Small Bowel Metastases From Malignant Phyllodes Breast Tumor Detected by 18 F-FDG PET/CT.
Yuan M; Han B; Zhang N; Lu L; Liu S
Clin Nucl Med; 2023 Nov; 48(11):967-968. PubMed ID: 37796182
[TBL] [Abstract][Full Text] [Related]
11. Brain Death Confirmation by 18F-FDG PET/CT: A Case Series.
Yousefi-Koma A; Sadegh-Beigee F; Ghorbani F; Mirbahaeddin K; Aghahosseini F; Alibeigi E; Jarrah N
Exp Clin Transplant; 2023 Sep; 21(9):756-763. PubMed ID: 37885292
[TBL] [Abstract][Full Text] [Related]
12. Overview of F18-FDG uptake patterns in retroperitoneal pathologies: imaging findings, pitfalls, and artifacts.
Pathak P; Abandeh L; Aboughalia H; Pooyan A; Mansoori B
Abdom Radiol (NY); 2024 May; 49(5):1677-1698. PubMed ID: 38652126
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT findings of breast metastasis from lung adenocarcinoma.
Biner IU; Orkan GS; Yilmaz U
Jpn J Clin Oncol; 2024 May; 54(5):606-608. PubMed ID: 38346918
[No Abstract] [Full Text] [Related]
14. Application of PET Tracers in Molecular Imaging for Breast Cancer.
Boers J; de Vries EFJ; Glaudemans AWJM; Hospers GAP; Schröder CP
Curr Oncol Rep; 2020 Jul; 22(8):85. PubMed ID: 32627087
[TBL] [Abstract][Full Text] [Related]
15. Imaging Cancer Metabolism with Positron Emission Tomography (PET).
Witney TH; Lewis DY
Methods Mol Biol; 2019; 1928():29-44. PubMed ID: 30725448
[TBL] [Abstract][Full Text] [Related]
16. Quarter-Century Transformation of Oncology: Positron Emission Tomography for Patients with Breast Cancer.
Ulaner GA; Vaz SC; Groheux D
PET Clin; 2024 Apr; 19(2):147-162. PubMed ID: 38177052
[TBL] [Abstract][Full Text] [Related]
17. Immune PET Imaging.
Iyalomhe O; Farwell MD
Radiol Clin North Am; 2021 Sep; 59(5):875-886. PubMed ID: 34392924
[TBL] [Abstract][Full Text] [Related]
18. Clinical
Dumba M; Khan S; Patel N; Perry L; Malhotra P; Perry R; Nijran K; Barwick T; Wallitt K; Win Z
Br J Radiol; 2019 Sep; 92(1101):20181027. PubMed ID: 30982329
[TBL] [Abstract][Full Text] [Related]
19. Imaging for illuminating actionable pathways in breast cancer.
Gilardi L; Airò Farulla LS; Ceci F
Curr Opin Oncol; 2022 Nov; 34(6):606-613. PubMed ID: 36093891
[TBL] [Abstract][Full Text] [Related]
20. Anti-programmed-death-receptor-1 (PD-1) antibody (Pembrolizumab) induced pancreatitis diagnosed on 18F-FDG PET/CT.
Usmani S; Jain A; Riyami KA; Sayani R; Jayakrishnan VV
J Pak Med Assoc; 2024 Apr; 74(4):825-826. PubMed ID: 38751292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
